Oxford Nanopore raises $140M to set up sequencing showdown with Illumina

Great news — I wonder how low sequencing costs can go.

From Fierce Biotech:

“Oxford Nanopore Technologies (ONT) has tapped a global syndicate of investors for $140 million to fuel its attempts to upend the genome sequencing market. The financing equips ONT to scale up its operation as it moves deeper into territory currently colonized by Illumina and Pacific Biosciences.”